Prothena Corp Public (PRTA) FCF Margin Growth (3y) (2015 - 2026)
Prothena Corp Public (PRTA) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 224,675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224,675.00 |
| Dec 31, 2025 | -11.10 Mn |
| Sep 30, 2025 | 38,296.00 |
| Jun 30, 2025 | 164,964.00 |
| Mar 31, 2025 | 135,848.00 |
| Dec 31, 2024 | -30,881.00 |
| Sep 30, 2024 | -473,968.00 |
| Jun 30, 2024 | -4,898.00 |
| Mar 31, 2024 | -12.52 Mn |
| Dec 31, 2023 | -1.13 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 847,475.00 |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 569,051.00 |
| Sep 30, 2022 | 242,082.00 |
| Jun 30, 2022 | 458,862.00 |
| Mar 31, 2022 | 619,716.00 |
| Dec 31, 2021 | 969,987.00 |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | -2.07 Mn |